Fredun Pharmaceuticals Limited (FREDUN)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,278.20+4.63%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

₹228 cr

Revenue YoY

+90.7%

Net profit

₹13 cr

Profit YoY

+94.1%

Net margin

5.8%

P/E

61.2

Forward P/E

0.0

P/B

8.58

Book value

₹169.39

EPS (TTM)

₹23.09

52-week high

₹1,536.00

52-week low

₹1,320.10

50-day MA

₹1,454.81

200-day MA

₹1,454.81

Beta

0.76

Promoters

55.06%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Fredun Pharmaceuticals Limited — free to start.

Data updated 2026-09-18.